Carisma Therapeutics Inc. financial data

Symbol
CARM on Nasdaq
Industry
Pharmaceutical Preparations
Location
3675 Market Street, Suite 200, Philadelphia, PA
State of incorporation
PA
Fiscal year end
December 31
Former names
Sesen Bio, Inc. (to 3/6/2023), Eleven Biotherapeutics, Inc. (to 5/16/2018)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 410 % -29.5%
Debt-to-equity 115 % +62.9%
Return On Equity -957 % -63.3%
Return On Assets -96.4 % -36.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41.8M shares +3.45%
Common Stock, Shares, Outstanding 41.8M shares +3.59%
Entity Public Float 276M USD +70.6%
Common Stock, Value, Issued 41K USD +2.5%
Weighted Average Number of Shares Outstanding, Basic 41.6M shares +3.23%
Weighted Average Number of Shares Outstanding, Diluted 41.6M shares +3.23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 20.3M USD +42%
Research and Development Expense 63.5M USD -12.8%
General and Administrative Expense 23.5M USD +1.55%
Operating Income (Loss) -66.8M USD +18.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -63.8M USD +22.8%
Earnings Per Share, Basic -0.68 USD/shares +93.6%
Earnings Per Share, Diluted -0.68 USD/shares +93.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.9M USD -67.7%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 26.9M USD -71.4%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 34.1M USD -65%
Property, Plant and Equipment, Net 7.38M USD
Operating Lease, Right-of-Use Asset 2.32M USD +39.5%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 0 USD -100%
Assets 42.1M USD -60.6%
Accounts Payable, Current 1.73M USD -28.3%
Employee-related Liabilities, Current 2.31M USD +28.6%
Accrued Liabilities, Current 4.54M USD -35.4%
Liabilities, Current 10.6M USD -18.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 761K USD -14.6%
Other Liabilities, Noncurrent 519K USD -55.9%
Liabilities 53.2M USD -12.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -288M USD -28.5%
Stockholders' Equity Attributable to Parent 26.5M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -11.1M USD -124%
Liabilities and Equity 42.1M USD -60.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.4M USD +12.2%
Net Cash Provided by (Used in) Financing Activities 1.35M USD -98%
Net Cash Provided by (Used in) Investing Activities -17K USD +99.5%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 41.8M shares +3.59%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.15M USD -86.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26.9M USD -67.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50K USD +11.1%
Deferred Tax Assets, Valuation Allowance 134M USD +172%
Deferred Tax Assets, Gross 135M USD +165%
Operating Lease, Liability 2.15M USD +22.9%
Payments to Acquire Property, Plant, and Equipment 17K USD -87.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -64.2M USD +30.8%
Lessee, Operating Lease, Liability, to be Paid 2.43M USD +14.3%
Property, Plant and Equipment, Gross 105K USD -89.6%
Operating Lease, Liability, Current 1.39M USD +61.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 226K USD +3.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 219K USD -45.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 284K USD -25.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 233K USD +3.1%
Deferred Tax Assets, Operating Loss Carryforwards 72.7M USD +169%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 240K USD +3%
Operating Lease, Payments 1.46M USD +1.04%
Additional Paid in Capital 277M USD +2.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.17M USD -34.8%
Share-based Payment Arrangement, Expense 3.67M USD +147%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares